ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves STELARA for Adolescents with Moderate to Severe Plaque Psoriasis
October 17, 2017Today's approval marks a significant milestone for this age group as approximately one-third of individuals who develop plaque psoriasis do so before 20 years of age, and there are limited treatment options for adolescents. -
Janssen Announces FDA Approval of TREMFYA for Severe Plaque Psoriasis
July 18, 2017Janssen Biotech announced the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment of adults living with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Pharma Sources Insight January 2025
